의료 분야 인공지능(AI) 시장 분석 및 예측(-2035년) : 유형, 제품 유형, 기술, 구성요소, 용도, 도입 형태, 최종사용자, 솔루션, 제공 형태별

The global Artificial Intelligence in Healthcare Market is projected to grow from $14.6 billion in 2025 to $102.7 billion by 2035, at a compound annual growth rate (CAGR) of 21.8%. Growth is driven by advancements in machine learning, increasing healthcare data, personalized medicine demand, and AI's role in diagnostics and patient care efficiency. The Artificial Intelligence in Healthcare Market is characterized by several leading segments, with machine learning holding approximately 35% market share, followed by natural language processing at 25%, and robotic process automation at 20%. Key applications include diagnostics, personalized medicine, and hospital management systems. The market is moderately consolidated, with a few dominant players and numerous smaller firms contributing to a diverse ecosystem. Volume insights indicate a growing number of AI installations in healthcare facilities, driven by the increasing adoption of AI-powered diagnostic tools and patient management systems.

The competitive landscape features a mix of global and regional players, with significant contributions from technology giants and specialized healthcare AI firms. The degree of innovation is high, with continuous advancements in AI algorithms and integration with existing healthcare systems. Mergers and acquisitions, along with strategic partnerships, are prevalent as companies seek to expand their technological capabilities and market reach. Notable trends include collaborations between tech companies and healthcare providers to develop AI-driven solutions that enhance patient outcomes and operational efficiency.

The Type segment in the AI in Healthcare market is primarily driven by the increasing adoption of machine learning and natural language processing technologies. Machine learning dominates due to its ability to analyze complex datasets and improve diagnostic accuracy, while natural language processing is crucial for managing unstructured data in clinical documentation. These technologies are pivotal in enhancing patient care and operational efficiency, with significant demand from hospitals and research institutions seeking to leverage AI for predictive analytics and personalized medicine.

In the Technology segment, deep learning and computer vision are at the forefront, driven by their applications in medical imaging and diagnostics. Deep learning algorithms excel in pattern recognition, enabling more accurate interpretation of medical images, which is critical in radiology and pathology. Computer vision is increasingly used for surgical assistance and monitoring patient vitals. The ongoing advancements in AI algorithms and the integration of AI with IoT devices are propelling growth, particularly in developed regions with advanced healthcare infrastructure.

The Application segment sees significant traction in the areas of diagnostics and personalized medicine. Diagnostics is the leading subsegment, as AI enhances the speed and accuracy of disease detection, particularly in oncology and cardiology. Personalized medicine is gaining momentum with AI's ability to tailor treatments based on individual genetic profiles. The demand is driven by the need for precision healthcare solutions and the growing emphasis on preventive care, supported by the increasing availability of patient data and advanced analytics tools.

Within the End User segment, hospitals and healthcare providers are the primary drivers of AI adoption. Hospitals leverage AI to improve patient outcomes, streamline operations, and reduce costs through enhanced decision-making and workflow automation. Healthcare providers use AI for patient management and treatment planning. The trend towards digital transformation in healthcare, coupled with the pressure to deliver value-based care, is encouraging these end users to invest heavily in AI technologies.

The Component segment is dominated by software solutions, which form the backbone of AI applications in healthcare. AI software platforms are essential for data management, algorithm development, and deployment of AI models in clinical settings. Hardware components, such as GPUs and processors, are also critical, supporting the computational needs of AI systems. The increasing complexity of AI models and the need for real-time data processing are driving investments in both software and hardware, with cloud-based solutions gaining popularity for their scalability and flexibility.

Geographical Overview

North America: The North American AI in healthcare market is highly mature, driven by robust technological infrastructure and significant investment in R&D. The United States leads the region, with a strong focus on precision medicine and digital health solutions. Key industries include biotechnology, pharmaceuticals, and medical devices, which are increasingly integrating AI to enhance patient outcomes and operational efficiency.

Europe: Europe exhibits moderate market maturity, with countries like the UK, Germany, and France spearheading AI adoption in healthcare. The region benefits from supportive regulatory frameworks and a focus on digital health transformation. Key industries driving demand include healthcare IT, diagnostics, and telemedicine, as AI technologies are leveraged to improve healthcare delivery and patient care.

Asia-Pacific: The Asia-Pacific region is experiencing rapid growth in AI healthcare applications, with countries like China, Japan, and India leading the charge. The market is characterized by increasing investments in AI startups and government initiatives to enhance healthcare infrastructure. Key industries include hospital management, diagnostics, and wearable technology, as AI is utilized to address the challenges of large populations and diverse healthcare needs.

Latin America: The Latin American AI in healthcare market is in the nascent stage, with Brazil and Mexico being notable contributors. The region is gradually adopting AI technologies to improve healthcare accessibility and efficiency. Key industries include telemedicine, healthcare IT, and diagnostics, as AI solutions are implemented to overcome regional healthcare disparities and resource constraints.

Middle East & Africa: The Middle East & Africa region is emerging in the AI healthcare market, with the UAE and South Africa at the forefront. The market is driven by government initiatives and investments in healthcare innovation. Key industries include hospital management and telemedicine, as AI is deployed to enhance healthcare delivery in remote areas and improve overall system efficiency.

Key Trends and Drivers

Trend 1 Title: Integration of AI in Diagnostic Imaging

The integration of artificial intelligence in diagnostic imaging is revolutionizing the healthcare industry by enhancing the accuracy and efficiency of medical imaging. AI algorithms are increasingly being used to analyze complex imaging data, enabling faster and more precise diagnosis of conditions such as cancer, cardiovascular diseases, and neurological disorders. This trend is driven by the need for improved diagnostic tools, the growing volume of imaging procedures, and the demand for reducing human error in radiology.

Trend 2 Title: Personalized Medicine and AI

AI is playing a crucial role in advancing personalized medicine by enabling the analysis of large datasets to identify patterns and predict individual responses to treatments. This trend is fueled by the increasing availability of genomic data and the need for tailored therapeutic approaches that consider an individual's genetic makeup, lifestyle, and environment. AI-driven personalized medicine is expected to improve patient outcomes, reduce adverse drug reactions, and optimize treatment plans, thereby transforming healthcare delivery.

Trend 3 Title: AI-Powered Virtual Health Assistants

The adoption of AI-powered virtual health assistants is on the rise, providing patients with 24/7 access to healthcare information and support. These digital assistants leverage natural language processing and machine learning to offer personalized health advice, schedule appointments, and manage chronic conditions. This trend is driven by the growing demand for convenient and cost-effective healthcare solutions, as well as the increasing use of telemedicine and remote patient monitoring technologies.

Trend 4 Title: Regulatory Advancements in AI Healthcare Applications

Regulatory bodies are increasingly recognizing the potential of AI in healthcare and are working towards creating frameworks that ensure the safe and effective use of AI technologies. This trend involves the development of guidelines and standards for AI applications, addressing issues such as data privacy, algorithm transparency, and patient safety. Regulatory advancements are crucial for fostering innovation while ensuring that AI solutions meet stringent healthcare standards and gain widespread adoption.

Trend 5 Title: AI in Drug Discovery and Development

AI is transforming the drug discovery and development process by significantly reducing the time and cost associated with bringing new drugs to market. Machine learning algorithms are being used to identify potential drug candidates, predict their efficacy, and optimize clinical trial designs. This trend is driven by the pharmaceutical industry's need to accelerate R&D processes and improve success rates. AI's ability to analyze vast datasets and generate insights is proving invaluable in the quest for novel therapeutics and personalized treatment options.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Technology
• 2.4 Key Market Highlights by Component
• 2.5 Key Market Highlights by Application
• 2.6 Key Market Highlights by End User
• 2.7 Key Market Highlights by Deployment
• 2.8 Key Market Highlights by Solutions
• 2.9 Key Market Highlights by Mode

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Machine Learning
  • 4.1.2 Natural Language Processing
  • 4.1.3 Computer Vision
  • 4.1.4 Robotics
  • 4.1.5 Others
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 AI-based Software
  • 4.2.2 AI-based Hardware
  • 4.2.3 AI-based Services
  • 4.2.4 Others
• 4.3 Market Size & Forecast by Technology (2020-2035)
  • 4.3.1 Deep Learning
  • 4.3.2 Predictive Analytics
  • 4.3.3 Speech Recognition
  • 4.3.4 Image Recognition
  • 4.3.5 Others
• 4.4 Market Size & Forecast by Component (2020-2035)
  • 4.4.1 Software
  • 4.4.2 Hardware
  • 4.4.3 Services
  • 4.4.4 Others
• 4.5 Market Size & Forecast by Application (2020-2035)
  • 4.5.1 Clinical Trials
  • 4.5.2 Robot-Assisted Surgery
  • 4.5.3 Virtual Nursing Assistants
  • 4.5.4 Administrative Workflow Assistance
  • 4.5.5 Fraud Detection
  • 4.5.6 Diagnosis and Treatment
  • 4.5.7 Patient Management
  • 4.5.8 Others
• 4.6 Market Size & Forecast by End User (2020-2035)
  • 4.6.1 Hospitals
  • 4.6.2 Pharmaceutical Companies
  • 4.6.3 Research Laboratories
  • 4.6.4 Healthcare Providers
  • 4.6.5 Others
• 4.7 Market Size & Forecast by Deployment (2020-2035)
  • 4.7.1 Cloud-Based
  • 4.7.2 On-Premises
  • 4.7.3 Hybrid
  • 4.7.4 Others
• 4.8 Market Size & Forecast by Solutions (2020-2035)
  • 4.8.1 Patient Data & Risk Analytics
  • 4.8.2 Medical Imaging & Diagnostics
  • 4.8.3 Lifestyle Management & Monitoring
  • 4.8.4 Virtual Assistants
  • 4.8.5 Others
• 4.9 Market Size & Forecast by Mode (2020-2035)
  • 4.9.1 B2B
  • 4.9.2 B2C
  • 4.9.3 Others

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Technology
    • 5.2.1.4 Component
    • 5.2.1.5 Application
    • 5.2.1.6 End User
    • 5.2.1.7 Deployment
    • 5.2.1.8 Solutions
    • 5.2.1.9 Mode
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Technology
    • 5.2.2.4 Component
    • 5.2.2.5 Application
    • 5.2.2.6 End User
    • 5.2.2.7 Deployment
    • 5.2.2.8 Solutions
    • 5.2.2.9 Mode
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Technology
    • 5.2.3.4 Component
    • 5.2.3.5 Application
    • 5.2.3.6 End User
    • 5.2.3.7 Deployment
    • 5.2.3.8 Solutions
    • 5.2.3.9 Mode
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Technology
    • 5.3.1.4 Component
    • 5.3.1.5 Application
    • 5.3.1.6 End User
    • 5.3.1.7 Deployment
    • 5.3.1.8 Solutions
    • 5.3.1.9 Mode
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Technology
    • 5.3.2.4 Component
    • 5.3.2.5 Application
    • 5.3.2.6 End User
    • 5.3.2.7 Deployment
    • 5.3.2.8 Solutions
    • 5.3.2.9 Mode
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Technology
    • 5.3.3.4 Component
    • 5.3.3.5 Application
    • 5.3.3.6 End User
    • 5.3.3.7 Deployment
    • 5.3.3.8 Solutions
    • 5.3.3.9 Mode
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Technology
    • 5.4.1.4 Component
    • 5.4.1.5 Application
    • 5.4.1.6 End User
    • 5.4.1.7 Deployment
    • 5.4.1.8 Solutions
    • 5.4.1.9 Mode
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Technology
    • 5.4.2.4 Component
    • 5.4.2.5 Application
    • 5.4.2.6 End User
    • 5.4.2.7 Deployment
    • 5.4.2.8 Solutions
    • 5.4.2.9 Mode
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Technology
    • 5.4.3.4 Component
    • 5.4.3.5 Application
    • 5.4.3.6 End User
    • 5.4.3.7 Deployment
    • 5.4.3.8 Solutions
    • 5.4.3.9 Mode
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Technology
    • 5.4.4.4 Component
    • 5.4.4.5 Application
    • 5.4.4.6 End User
    • 5.4.4.7 Deployment
    • 5.4.4.8 Solutions
    • 5.4.4.9 Mode
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Technology
    • 5.4.5.4 Component
    • 5.4.5.5 Application
    • 5.4.5.6 End User
    • 5.4.5.7 Deployment
    • 5.4.5.8 Solutions
    • 5.4.5.9 Mode
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Technology
    • 5.4.6.4 Component
    • 5.4.6.5 Application
    • 5.4.6.6 End User
    • 5.4.6.7 Deployment
    • 5.4.6.8 Solutions
    • 5.4.6.9 Mode
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Technology
    • 5.4.7.4 Component
    • 5.4.7.5 Application
    • 5.4.7.6 End User
    • 5.4.7.7 Deployment
    • 5.4.7.8 Solutions
    • 5.4.7.9 Mode
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Technology
    • 5.5.1.4 Component
    • 5.5.1.5 Application
    • 5.5.1.6 End User
    • 5.5.1.7 Deployment
    • 5.5.1.8 Solutions
    • 5.5.1.9 Mode
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Technology
    • 5.5.2.4 Component
    • 5.5.2.5 Application
    • 5.5.2.6 End User
    • 5.5.2.7 Deployment
    • 5.5.2.8 Solutions
    • 5.5.2.9 Mode
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Technology
    • 5.5.3.4 Component
    • 5.5.3.5 Application
    • 5.5.3.6 End User
    • 5.5.3.7 Deployment
    • 5.5.3.8 Solutions
    • 5.5.3.9 Mode
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Technology
    • 5.5.4.4 Component
    • 5.5.4.5 Application
    • 5.5.4.6 End User
    • 5.5.4.7 Deployment
    • 5.5.4.8 Solutions
    • 5.5.4.9 Mode
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Technology
    • 5.5.5.4 Component
    • 5.5.5.5 Application
    • 5.5.5.6 End User
    • 5.5.5.7 Deployment
    • 5.5.5.8 Solutions
    • 5.5.5.9 Mode
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Technology
    • 5.5.6.4 Component
    • 5.5.6.5 Application
    • 5.5.6.6 End User
    • 5.5.6.7 Deployment
    • 5.5.6.8 Solutions
    • 5.5.6.9 Mode
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Technology
    • 5.6.1.4 Component
    • 5.6.1.5 Application
    • 5.6.1.6 End User
    • 5.6.1.7 Deployment
    • 5.6.1.8 Solutions
    • 5.6.1.9 Mode
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Technology
    • 5.6.2.4 Component
    • 5.6.2.5 Application
    • 5.6.2.6 End User
    • 5.6.2.7 Deployment
    • 5.6.2.8 Solutions
    • 5.6.2.9 Mode
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Technology
    • 5.6.3.4 Component
    • 5.6.3.5 Application
    • 5.6.3.6 End User
    • 5.6.3.7 Deployment
    • 5.6.3.8 Solutions
    • 5.6.3.9 Mode
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Technology
    • 5.6.4.4 Component
    • 5.6.4.5 Application
    • 5.6.4.6 End User
    • 5.6.4.7 Deployment
    • 5.6.4.8 Solutions
    • 5.6.4.9 Mode
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Technology
    • 5.6.5.4 Component
    • 5.6.5.5 Application
    • 5.6.5.6 End User
    • 5.6.5.7 Deployment
    • 5.6.5.8 Solutions
    • 5.6.5.9 Mode

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 IBM
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Microsoft
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Google
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Amazon
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Siemens Healthineers
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Philips Healthcare
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 GE Healthcare
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Medtronic
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Cerner Corporation
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Epic Systems Corporation
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 NVIDIA
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Intel Corporation
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Nuance Communications
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Allscripts Healthcare Solutions
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Zebra Medical Vision
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 iCarbonX
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Tempus Labs
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 PathAI
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Butterfly Network
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Viz.ai
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us